Quantcast
Home / Opinion / Commentary / Reforming FDA, not price control, is path to cheaper drugs

Reforming FDA, not price control, is path to cheaper drugs

It is easy to see the political allure of “cheap drugs,” but what is often ignored by advocates of market distorting price controls is the long-term impact such policies will have on medical innovation and access.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

 

x

Check Also

child-foster-safety-620

State agency turns its back on kids who need support

One of the guiding principles listed on the Arizona Department of Child Safety website is: “All Arizona’s children are safe and protected from harm.”